Involvement of progenitor cells in vascular repair

Trends in Cardiovascular Medicine

Volumn 13, Issue 8, 2003, Pages 322-326

  Hibbert, Benjamin ^a   Olsen, Steve ^a   O'Brien, Edward ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTERY LESION; ARTERY OCCLUSION; BLOOD VESSEL INJURY; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; DISEASE COURSE; DISEASE MODEL; ENDOTHELIUM CELL; HUMAN; IMPLANTATION; IN VITRO STUDY; MONONUCLEAR CELL; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL; TISSUE REGENERATION; TISSUE REPAIR; VASCULAR DISEASE;

ANIMALS; CELL ADHESION; DISEASE MODELS, ANIMAL; HUMANS; MUSCLE, SMOOTH, VASCULAR; STEM CELL TRANSPLANTATION; STEM CELLS; STENTS; VASCULAR DISEASES;

EID: 0242270762     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2003.09.002     Document Type: Review

References (39)

1. Arciniegas E., Sutton A.B., Allen T.D., Schor A.M. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci. 103:1992;521-529.
2. Asahara T., Murohara T., Sullivan A.et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:1997;964-967.
3. Benditt E.P., Benditt J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA. 70:1973;1753-1756.
4. Campbell J.H., Han C.L., Campbell G.R. Neointimal formation by circulating bone marrow cells. Ann NY Acad Sci. 947:2001;18-24.
5. deRuiter M.C., Poelmann R.E., Vanlperen L., Gittenberger-de Groot A.C. The early development of the tunica media in the vascular system of rat embryos. Anat Embryol (Berl). 181:1990;341-349.
6. deRuiter M.C., Poelmann R.E., VanMunsteren J.C.et al. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res. 80:1997;444-451.
7. Farb A., Sangiorgi G., Carter A.J.et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 99:1999;44-52.
8. Feigl W., Susani M., Ulrich W.et al. Organisation of experimental thrombosis by blood cells. Evidence of the transformation of mononuclear cells into myofibroblasts and endothelial cells. Virchows Arch A Pathol Anat Histopathol. 406:1985;133-148.
9. Frid M.G., Kale V.A., Stenmark K.R. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation. in vitro analysis Circ Res. 90:2002;1189-1196.
10. Froeschl M., Olsen S., Ma X., O'Brien E.R. Current understanding of in-stent restenosis and the potential benefit of drug eluting stents. Curr Drug Targets Cardiovasc Haematol Disord. in press:2003.
11. Glover C., Ma X., Chen Y.-X.et al. Human in-stent restenosis tissue obtained by coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation. Am Heart J. 144:2002;702-709.
12. Grimm P.C., Nickerson P., Jeffery J.et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med. 345:2002;93-97.
13. Hall S.M., Hislop A.A., Pierce C.M., Haworth S.G. Prenatal origins of human intrapulmonary arteries. Formation and smooth muscle maturation. Am J Respir Cell Mol Biol. 23:2000;194-203.
14. Hill J.M., Zalos G., Halcox J.P.et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 348:2003;593-600.
15. Hillebrands J.-L., Klatter F.A., Vandenhurk B.M.H.et al. Origin of neointimal endothelium and α-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest. 107(11):2001;1411-1422.
16. Hirschi K.K., Rohovsky S.A., Beck L.H.et al. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res. 84:1999;298-305.
17. Hirschi K.K., Burt J.M., Hirschi K.D., Dai C. Gap junction communication mediates transforming growth factor-beta activation and endothelial-induced mural cell differentiation. Circ Res. 93:2003;429-437.
18. Ishisaki A., Hayashi H., Li A.-J., Imamura T. Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J Biol Chem. 278:2003;1303-1309.
19. Kirby M.L., Waldo K.L. Role of neural crest in congenital heart disease. Circulation. 82:1990;332-340.
20. Kouchi Y., Onuki Y., Wu M.H.et al. Apparent blood stream origin of endothelial and smooth muscle cells in the neointima of long, impervious carotid-femoral grafts in the dog. Ann Vasc Surg. 12:1998;46-54.
21. Kozaki K., Kaminski W.E., Tang J.et al. Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in apoE null mice. Am J Pathol. 161:2002;1395-1407.
22. LeLievre C.S., Le Douarin N.M. Mesenchymal derivatives of the neural crest. analysis of chimaeric quail and chick embryos J Embryol Exp Morphol. 34:1975;125-154.
23. Lindahl P., Johansson B.R., Leeven P., Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 277:1997;242-245.
24. Majka S.M., Jackson K.A., Kienstra K.A.et al. Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest. 111:2003;71-79.
25. Mikawa T., Fischman D.A. Retroviral analysis of cardiac morphogenesis. discontinuous formation of coronary vessels Proc Natl Acad Sci USA. 89:1992;9504-9508.
26. Quaini F., Urbanek K., Beltrami A.P.et al. Chimerism of the transplanted heart. N Engl J Med. 346:2002;5-15.
27. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H.et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation. 108:2003;457-463.
28. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 107:2003;1164-1169.
29. Sata M., Saiura A., Kunisato A.et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 8:2002;403-409.
30. Schwartz S.M., deBlois D., O'Brien E.R. The intima. soil for atherosclerosis and restenosis Circ Res. 77:1995;445-465.
31. Shimizu K., Sugiyama S., Aikawa M.et al. Host bone-marrow cells are a source of donor intimal smooth muscle-like cells in murine aortic transplant arteriopathy. Nat Med. 7:2001;738-741.
32. Simper D., Stalboerger P.G., Panetta C.J.et al. Smooth muscle progenitor cells in human blood. Circulation. 106:2002;1199-1204.
33. Strehlow K., Werner N., Berweiler J.et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation. 107:2003;3059-3065.
34. Vasa M., Fichtlscherer S., Adler K.et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 103:2001;2885-2890. a.
35. Vasa M., Fichtlscherer S., Aicher A.et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 89:2001;e1-e7. b.
36. Walter D.H., Schachinger V., Elsner M.et al. Effect of statin therapy on restenosis after coronary stent implantation. Am J Cardiol. 85:2000;962-968.
37. Walter D.H., Rittig K., Bahlmann F.H.et al. Statin therapy accelerates reendothelialization. a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells Circulation. 105:2002;3017-3024.
38. Welt F.G., Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 22:2002;1769-1776.
39. Yamashita J., Itoh H., Hirashima.Met al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 408:2000;92-96.